chitosan scaffolds
Recently Published Documents


TOTAL DOCUMENTS

381
(FIVE YEARS 86)

H-INDEX

50
(FIVE YEARS 9)

2022 ◽  
Vol 17 (5) ◽  
pp. 1146
Author(s):  
Peng Hao ◽  
Zhao-Yang Yang ◽  
Xiao-Guang Li ◽  
Fa-Dong Liu ◽  
Hong-Mei Duan ◽  
...  

2021 ◽  
pp. 100039
Author(s):  
Elif Saatcioglu ◽  
Muge Koyun ◽  
Songul Ulag ◽  
Ali Sahin ◽  
Betul Karademir Yilmaz ◽  
...  

2021 ◽  
Author(s):  
Xiao-Yin Liu ◽  
Chong Chen ◽  
Hai-Huan Xu ◽  
Yu-sheng Zhang ◽  
Lin Zhong ◽  
...  

Abstract Recent studies have shown that 3D printed scaffolds integrated with growth factors can guide the growth of neurites and promote axon regeneration at the injury site. However, heat, organic solvents or cross-linking agents used in conventional 3D printing reduce the biological activity of growth factors. Low temperature 3D printing can incorporate growth factors into the scaffold and maintain their biological activity. In this study, we developed a collagen/chitosan scaffold integrated with brain-derived neurotrophic factor (3D-CC-BDNF) by low temperature extrusion 3D printing as a new type of artificial controlled release system, which could prolong the release of BDNF for the treatment of SCI. 8 weeks after the implantation of scaffolds in the transected lesion of T10 of the spinal cord, 3D-CC-BDNF significantly ameliorate locomotor function of the rats. Consistent with the recovery of locomotor function, 3D-CC-BDNF treatment could fill the gap, facilitate nerve fiber regeneration, accelerate the establishment of synaptic connections and enhance remyelination at the injury site.


2021 ◽  
Vol 22 (15) ◽  
pp. 7901
Author(s):  
Luca Scaccini ◽  
Roberta Mezzena ◽  
Alessia De Masi ◽  
Mariacristina Gagliardi ◽  
Giovanna Gambarotta ◽  
...  

Peripheral nerve injuries are a common condition in which a nerve is damaged, affecting more than one million people every year. There are still no efficient therapeutic treatments for these injuries. Artificial scaffolds can offer new opportunities for nerve regeneration applications; in this framework, chitosan is emerging as a promising biomaterial. Here, we set up a simple and effective method for the production of micro-structured chitosan films by solvent casting, with high fidelity in the micro-pattern reproducibility. Three types of chitosan directional micro-grooved patterns, presenting different levels of symmetricity, were developed for application in nerve regenerative medicine: gratings (GR), isosceles triangles (ISO) and scalene triangles (SCA). The directional patterns were tested with a Schwann cell line. The most asymmetric topography (SCA), although it polarized the cell shaping less efficiently, promoted higher cell proliferation and a faster cell migration, both individually and collectively, with a higher directional persistence of motion. Overall, the use of micro-structured asymmetrical directional topographies may be exploited to enhance the nerve regeneration process mediated by chitosan scaffolds.


Author(s):  
Golnaz Navidi ◽  
Maryam Allahvirdinesbat ◽  
Seyed Mohammad Mousavi Al-Molki ◽  
Soodabeh Davaran ◽  
Parvaneh Nakhostin Panahi ◽  
...  

2021 ◽  
pp. 118440
Author(s):  
Jue Hu ◽  
ZhuoZhi Wang ◽  
Jacob M. Miszuk ◽  
Min Zhu ◽  
Thiranjeewa I. Lansakara ◽  
...  

Biomedicines ◽  
2021 ◽  
Vol 9 (6) ◽  
pp. 590
Author(s):  
Lucy Vojtová ◽  
Veronika Pavliňáková ◽  
Johana Muchová ◽  
Katarína Kacvinská ◽  
Jana Brtníková ◽  
...  

Wound healing is a process regulated by a complex interaction of multiple growth factors including fibroblast growth factor 2 (FGF2). Although FGF2 appears in several tissue engineered studies, its applications are limited due to its low stability both in vitro and in vivo. Here, this shortcoming is overcome by a unique nine-point mutant of the low molecular weight isoform FGF2 retaining full biological activity even after twenty days at 37 °C. Crosslinked freeze-dried 3D porous collagen/chitosan scaffolds enriched with this hyper stable recombinant human protein named FGF2-STAB® were tested for in vitro biocompatibility and cytotoxicity using murine 3T3-A31 fibroblasts, for angiogenic potential using an ex ovo chick chorioallantoic membrane assay and for wound healing in vivo with 3-month old white New Zealand rabbits. Metabolic activity assays indicated the positive effect of FGF2-STAB® already at very low concentrations (0.01 µg/mL). The angiogenic properties examined ex ovo showed enhanced vascularization of the tested scaffolds. Histological evaluation and gene expression analysis by RT-qPCR proved newly formed granulation tissue at the place of a previous skin defect without significant inflammation infiltration in vivo. This work highlights the safety and biocompatibility of newly developed crosslinked collagen/chitosan scaffolds involving FGF2-STAB® protein. Moreover, these sponges could be used as scaffolds for growing cells for dermis replacement, where neovascularization is a crucial parameter for successful skin regeneration.


Sign in / Sign up

Export Citation Format

Share Document